Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 511 to 525 of 975 results for death

  1. Identifying infection in women with preterm prelabour rupture of membranes (P-PROM):- What is the diagnostic accuracy of serial C-reactive protein testing to identify chorioamnionitis in women with P-PROM?

    particularly important given that sepsis is a common direct cause of maternal death. There is currently limited evidence that serial...

    Research recommendation
    Published
    11 December 2015

  2. Recognising that a child or young person may be dying:- What signs and symptoms indicate that a child or young person with a life-limiting condition is likely to die within hours or days?

    are often asked to estimate how close a child or young person may be to death. There is very little evidence on which to base any such...

    Research recommendation
    Published
    15 February 2017

  3. Communication:- What are the most clinically effective and cost-effective methods of addressing patient and carer concerns about strong opioids, including anticipating and managing adverse effects, and engaging patients in prescribing decisions?

    especially morphine, can be negatively associated with adverse effects and death. To improve adherence and to enable patients and carers...

    Research recommendation
    Published
    9 June 2015

  4. What are the implications of FH for the safety of a mother during pregnancy and what are the risks of fetal malformations attributable to pharmacological therapies

    is also limited information on the risk of pregnancy (including cardiac death) in a woman with FH. Data on the incidence of cardiac...

    Research recommendation
    Published
    15 November 2019

  5. Signs and symptoms that predict neutropenic sepsis in the community:- A prospective study should be carried out to determine which signs and symptoms experienced by patients in the community predict neutropenic sepsis and the outcomes of these episodes.

    too narrow will delay the emergency treatment of infection and may lead to death, increased need for intensive or critical care...

    Research recommendation
    Published
    9 June 2015

  6. Perinatal palliative care:- What impact does timely perinatal palliative care have on the experience of bereaved parents?

    after birth.There is little evidence on the experience families have of the death of a baby with or without specific support from a...

    Research recommendation
    Published
    15 February 2017

  7. Axicabtagene ciloleucel for treating relapsed or refractory diffuse large B-cell lymphoma after first-line chemoimmunotherapy (TA895)

    Evidence-based recommendations on axicabtagene ciloleucel (Yescarta) for treating relapsed or refractory diffuse large B-cell lymphoma after first-line chemoimmunotherapy.

    Technology appraisal guidance
    Published
    7 June 2023
    View recommendations

    Sections for TA895

  8. Mexiletine for treating the symptoms of myotonia in non-dystrophic myotonic disorders (TA748)

    Evidence-based recommendations on mexiletine (Namuscla) for treating the symptoms of myotonia in adults with non-dystrophic myotonic disorders.

    Technology appraisal guidance
    Published
    1 December 2021
    View recommendations

    Sections for TA748

  9. Vandetanib for treating medullary thyroid cancer (TA550)

    Evidence-based recommendations on vandetanib (Caprelsa) for treating medullary thyroid cancer in adults.

    Technology appraisal guidance
    Published
    12 December 2018
    View recommendations

    Sections for TA550

  10. Tildrakizumab for treating moderate to severe plaque psoriasis (TA575)

    Evidence-based recommendations on tildrakizumab (Ilumetri) for treating moderate to severe plaque psoriasis in adults.

    Technology appraisal guidance
    Published
    17 April 2019
    View recommendations

    Sections for TA575

  11. Early revascularisation strategy for people with angina and multivessel disease:- In people with stable angina and multivessel disease (including left main stem disease) whose symptoms are controlled with optimal drug treatment, would an initial treatment strategy of revascularisation be clinically and cost effective compared with continued drug treatment?

    tests to identify whether they have a higher risk profile for early cardiac death, which could be reduced by revascularisation. This...

    Research recommendation
    Published
    9 June 2015

  12. Integrated patient information systems:- What is the clinical and cost effectiveness of different methods for integrating patient information throughout the emergency medical care pathway?

    multidisciplinary orcomplex care needs, and recognising a person's preferred place of death in palliative care. In many locations around...

    Research recommendation
    Published
    15 November 2018

  13. Ticagrelor for preventing atherothrombotic events after myocardial infarction (TA420)

    Evidence-based recommendations on ticagrelor (Brilique) for preventing atherothrombotic events after myocardial infarction in adults.

    Technology appraisal guidance
    Published
    14 December 2016
    View recommendations

    Sections for TA420

  14. Prognostic tools:- Is the amyotrophic lateral sclerosis (ALS) Prognostic Index an accurate predictor of survival in people with MND under NHS care in England and/or Wales?

    being more aware of the likely progression and prepare themselves for the death of their loved one.Accurate predictions of survival...

    Research recommendation
    Published
    21 March 2016

  15. What is the optimal way of discharging people approaching the end of their life from hospitals back to their place of residence?

    the person's place of residence, such as a nursing home, especially when death is imminent. Such discharges are often delayed because of...

    Research recommendation
    Published
    18 November 2019